Europe Next-Generation Biologics Market Report 2016

Publisher Name :
Date: 22-Nov-2016
No. of pages: 104
Inquire Before Buying

Notes:

Sales, means the sales volume of Next-Generation Biologics

Revenue, means the sales value of Next-Generation Biologics

This report studies sales (consumption) of Next-Generation Biologics in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Allergan

- Bayer

- Biogen Idec

- Eli Lilly

- Kyowa Hakko Kirin

- Molecular Partners

- Novo Nordisk

- Pfizer

- Roche

- Sanofi

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Next-Generation Biologics in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Antibodies

- Regenerative medicine

- Insulins

- Growth hormones

- Other

Split by application, this report focuses on sales, market share and growth rate of Next-Generation Biologics in each application, can be divided into

- Medical

- Scientific Research

- Other

Europe Next-Generation Biologics Market Report 2016

Table of Contents
Europe Next-Generation Biologics Market Report 2016
1 Next-Generation Biologics Overview
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Classification of Next-Generation Biologics
1.2.1 Antibodies
1.2.2 Regenerative medicine
1.2.3 Insulins
1.2.4 Growth hormones
1.2.5 Other
1.3 Application of Next-Generation Biologics
1.3.1 Medical
1.3.2 Scientific Research
1.3.3 Other
1.4 Next-Generation Biologics Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Next-Generation Biologics (2011-2021)
1.5.1 Europe Next-Generation Biologics Sales and Growth Rate (2011-2021)
1.5.2 Europe Next-Generation Biologics Revenue and Growth Rate (2011-2021)
2 Europe Next-Generation Biologics by Manufacturers, Type and Application
2.1 Europe Next-Generation Biologics Market Competition by Manufacturers
2.1.1 Europe Next-Generation Biologics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Next-Generation Biologics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Next-Generation Biologics (Volume and Value) by Type
2.2.1 Europe Next-Generation Biologics Sales and Market Share by Type (2011-2016)
2.2.2 Europe Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
2.3 Europe Next-Generation Biologics (Volume and Value) by Countries
2.3.1 Europe Next-Generation Biologics Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Next-Generation Biologics Revenue and Market Share by Countries (2011-2016)
2.4 Europe Next-Generation Biologics (Volume) by Application
3 Germany Next-Generation Biologics (Volume, Value and Sales Price)
3.1 Germany Next-Generation Biologics Sales and Value (2011-2016)
3.1.1 Germany Next-Generation Biologics Sales and Growth Rate (2011-2016)
3.1.2 Germany Next-Generation Biologics Revenue and Growth Rate (2011-2016)
3.1.3 Germany Next-Generation Biologics Sales Price Trend (2011-2016)
3.2 Germany Next-Generation Biologics Sales and Market Share by Manufacturers
3.3 Germany Next-Generation Biologics Sales and Market Share by Type
3.4 Germany Next-Generation Biologics Sales and Market Share by Application
4 France Next-Generation Biologics (Volume, Value and Sales Price)
4.1 France Next-Generation Biologics Sales and Value (2011-2016)
4.1.1 France Next-Generation Biologics Sales and Growth Rate (2011-2016)
4.1.2 France Next-Generation Biologics Revenue and Growth Rate (2011-2016)
4.1.4 France Next-Generation Biologics Sales Price Trend (2011-2016)
4.2 France Next-Generation Biologics Sales and Market Share by Manufacturers
4.3 France Next-Generation Biologics Sales and Market Share by Type
4.4 France Next-Generation Biologics Sales and Market Share by Application
5 UK Next-Generation Biologics (Volume, Value and Sales Price)
5.1 UK Next-Generation Biologics Sales and Value (2011-2016)
5.1.1 UK Next-Generation Biologics Sales and Growth Rate (2011-2016)
5.1.2 UK Next-Generation Biologics Revenue and Growth Rate (2011-2016)
5.1.5 UK Next-Generation Biologics Sales Price Trend (2011-2016)
5.2 UK Next-Generation Biologics Sales and Market Share by Manufacturers
5.3 UK Next-Generation Biologics Sales and Market Share by Type
5.4 UK Next-Generation Biologics Sales and Market Share by Application
6 Russia Next-Generation Biologics (Volume, Value and Sales Price)
6.1 Russia Next-Generation Biologics Sales and Value (2011-2016)
6.1.1 Russia Next-Generation Biologics Sales and Growth Rate (2011-2016)
6.1.2 Russia Next-Generation Biologics Revenue and Growth Rate (2011-2016)
6.1.6 Russia Next-Generation Biologics Sales Price Trend (2011-2016)
6.2 Russia Next-Generation Biologics Sales and Market Share by Manufacturers
6.3 Russia Next-Generation Biologics Sales and Market Share by Type
6.4 Russia Next-Generation Biologics Sales and Market Share by Application
7 Italy Next-Generation Biologics (Volume, Value and Sales Price)
7.1 Italy Next-Generation Biologics Sales and Value (2011-2016)
7.1.1 Italy Next-Generation Biologics Sales and Growth Rate (2011-2016)
7.1.2 Italy Next-Generation Biologics Revenue and Growth Rate (2011-2016)
7.1.7 Italy Next-Generation Biologics Sales Price Trend (2011-2016)
7.2 Italy Next-Generation Biologics Sales and Market Share by Manufacturers
7.3 Italy Next-Generation Biologics Sales and Market Share by Type
7.4 Italy Next-Generation Biologics Sales and Market Share by Application
8 Spain Next-Generation Biologics (Volume, Value and Sales Price)
8.1 Spain Next-Generation Biologics Sales and Value (2011-2016)
8.1.1 Spain Next-Generation Biologics Sales and Growth Rate (2011-2016)
8.1.2 Spain Next-Generation Biologics Revenue and Growth Rate (2011-2016)
8.1.8 Spain Next-Generation Biologics Sales Price Trend (2011-2016)
8.2 Spain Next-Generation Biologics Sales and Market Share by Manufacturers
8.3 Spain Next-Generation Biologics Sales and Market Share by Type
8.4 Spain Next-Generation Biologics Sales and Market Share by Application
9 Benelux Next-Generation Biologics (Volume, Value and Sales Price)
9.1 Benelux Next-Generation Biologics Sales and Value (2011-2016)
9.1.1 Benelux Next-Generation Biologics Sales and Growth Rate (2011-2016)
9.1.2 Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Next-Generation Biologics Sales Price Trend (2011-2016)
9.2 Benelux Next-Generation Biologics Sales and Market Share by Manufacturers
9.3 Benelux Next-Generation Biologics Sales and Market Share by Type
9.4 Benelux Next-Generation Biologics Sales and Market Share by Application
10 Europe Next-Generation Biologics Manufacturers Analysis
10.1 Allergan
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Next-Generation Biologics Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Bayer
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Next-Generation Biologics Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Biogen Idec
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Next-Generation Biologics Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Eli Lilly
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Next-Generation Biologics Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Kyowa Hakko Kirin
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Next-Generation Biologics Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Molecular Partners
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Next-Generation Biologics Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Next-Generation Biologics Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Pfizer
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Next-Generation Biologics Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Roche
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Next-Generation Biologics Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Sanofi
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Next-Generation Biologics Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
11 Next-Generation Biologics Manufacturing Cost Analysis
11.1 Next-Generation Biologics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Next-Generation Biologics
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Next-Generation Biologics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Next-Generation Biologics Market Forecast (2016-2021)
14.1 Germany Next-Generation Biologics Sales Forecast (2016-2021)
14.2 France Next-Generation Biologics Sales Forecast (2016-2021)
14.3 UK Next-Generation Biologics Sales Forecast (2016-2021)
14.4 Russia Next-Generation Biologics Sales Forecast (2016-2021)
14.5 Italy Next-Generation Biologics Sales Forecast (2016-2021)
14.6 Spain Next-Generation Biologics Sales Forecast (2016-2021)
14.7 Benelux Next-Generation Biologics Sales Forecast (2016-2021)
14.8 Europe Next-Generation Biologics Sales Forecast by Type (2016-2021)
14.9 Europe Next-Generation Biologics Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Next-Generation Biologics
Table Classification of Next-Generation Biologics
Figure Europe Sales Market Share of Next-Generation Biologics by Type in 2015
Figure Antibodies Picture
Figure Regenerative medicine Picture
Figure Insulins Picture
Figure Growth hormones Picture
Figure Other Picture
Table Application of Next-Generation Biologics
Figure Europe Sales Market Share of Next-Generation Biologics by Application in 2015
Figure Medical Examples
Figure Scientific Research Examples
Figure Other Examples
Figure Germany Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure France Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure UK Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Russia Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Italy Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Spain Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Europe Next-Generation Biologics Sales and Growth Rate (2011-2021)
Figure Europe Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Table Europe Next-Generation Biologics Sales of Key Manufacturers (2015 and 2016)
Table Europe Next-Generation Biologics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Next-Generation Biologics Sales Share by Manufacturers
Figure 2016 Next-Generation Biologics Sales Share by Manufacturers
Table Europe Next-Generation Biologics Revenue by Manufacturers (2015 and 2016)
Table Europe Next-Generation Biologics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Next-Generation Biologics Revenue Share by Manufacturers
Table 2016 Europe Next-Generation Biologics Revenue Share by Manufacturers
Table Europe Next-Generation Biologics Sales and Market Share by Type (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Type (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Type (2011-2016)
Figure Europe Next-Generation Biologics Sales Growth Rate by Type (2011-2016)
Table Europe Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
Table Europe Next-Generation Biologics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Next-Generation Biologics by Type (2011-2016)
Figure Europe Next-Generation Biologics Revenue Growth Rate by Type (2011-2016)
Table Europe Next-Generation Biologics Sales and Market Share by Countries (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Countries (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Countries (2011-2016)
Table Europe Next-Generation Biologics Revenue and Market Share by Countries (2011-2016)
Table Europe Next-Generation Biologics Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Next-Generation Biologics by Countries (2011-2016)
Table Europe Next-Generation Biologics Sales and Market Share by Application (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Application (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Application (2011-2016)
Figure Germany Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Germany Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Germany Next-Generation Biologics Sales Price Trend (2011-2016)
Table Germany Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Germany Next-Generation Biologics Sales by Type (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Germany Next-Generation Biologics Sales by Application (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure France Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure France Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure France Next-Generation Biologics Sales Price Trend (2011-2016)
Table France Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table France Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table France Next-Generation Biologics Sales by Type (2015 and 2016)
Table France Next-Generation Biologics Market Share by Type (2015 and 2016)
Table France Next-Generation Biologics Sales by Application (2015 and 2016)
Table France Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure UK Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure UK Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure UK Next-Generation Biologics Sales Price Trend (2011-2016)
Table UK Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table UK Next-Generation Biologics Sales by Type (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Type (2015 and 2016)
Table UK Next-Generation Biologics Sales by Application (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Russia Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Russia Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Russia Next-Generation Biologics Sales Price Trend (2011-2016)
Table Russia Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Russia Next-Generation Biologics Sales by Type (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Russia Next-Generation Biologics Sales by Application (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Italy Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Italy Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Italy Next-Generation Biologics Sales Price Trend (2011-2016)
Table Italy Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Italy Next-Generation Biologics Sales by Type (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Italy Next-Generation Biologics Sales by Application (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Spain Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Spain Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Spain Next-Generation Biologics Sales Price Trend (2011-2016)
Table Spain Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Spain Next-Generation Biologics Sales by Type (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Spain Next-Generation Biologics Sales by Application (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Benelux Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Benelux Next-Generation Biologics Sales Price Trend (2011-2016)
Table Benelux Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Benelux Next-Generation Biologics Sales by Type (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Benelux Next-Generation Biologics Sales by Application (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Application (2015 and 2016)
Table Next-Generation Biologics Basic Information List
Table Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Next-Generation Biologics Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Next-Generation Biologics Sales Market Share (2011-2016)
Table Biogen Idec Basic Information List
Table Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogen Idec Next-Generation Biologics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Next-Generation Biologics Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Next-Generation Biologics Sales Market Share (2011-2016)
Table Molecular Partners Basic Information List
Table Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Molecular Partners Next-Generation Biologics Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Next-Generation Biologics Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Next-Generation Biologics Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Next-Generation Biologics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Next-Generation Biologics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Next-Generation Biologics
Figure Manufacturing Process Analysis of Next-Generation Biologics
Figure Next-Generation Biologics Industrial Chain Analysis
Table Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
Table Major Buyers of Next-Generation Biologics
Table Distributors/Traders List
Figure Germany Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Germany Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure France Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure France Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure UK Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure UK Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Russia Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Italy Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Spain Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Table Europe Next-Generation Biologics Sales Forecast by Type (2016-2021)
Table Europe Next-Generation Biologics Sales Forecast by Application (2016-2021)
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies [...]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new [...]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating [...]
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • United States DNA Sequencer Market Report 2017
    Published: 10-Apr-2017        Price: US 3800 Onwards        Pages: 101
    In this report, the United States DNA Sequencer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of DN......
  • EMEA (Europe, Middle East and Africa) Diving Equipments Market Report 2017
    Published: 04-Apr-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the EMEA Diving Equipments market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Diving Equipments for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022
    Published: 04-Apr-2017        Price: US 5650 Onwards        Pages: 215
    The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skille......
  • Global DNA Sequencer Sales Market Report 2017
    Published: 03-Apr-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global DNA Sequencer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of DNA Sequencer for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan -......
  • Global DNA Sequencer Market Research Report 2017
    Published: 28-Mar-2017        Price: US 2900 Onwards        Pages: 101
    In this report, the global DNA Sequencer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of DNA Sequencer in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021
    Published: 18-Jan-2017        Price: US 5650 Onwards        Pages: 195
    The in situ hybridization market is projected to reach USD 739.9 million by 2021 from USD 557.1 million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are some factors expected to drive the growth of the global in situ hybridization market in the coming years. In 2016, North America is exp......
  • Global DNA/RNA Extraction Kit Market Research Report 2017
    Published: 09-Jan-2017        Price: US 2900 Onwards        Pages: 118
    Notes: Production, means the output of DNA/RNA Extraction Kit Revenue, means the sales value of DNA/RNA Extraction Kit This report studies DNA/RNA Extraction Kit in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Thermo Fisher Scientific - Promega Corporation - Prim......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2017
    Published: 04-Jan-2017        Price: US 2900 Onwards        Pages: 124
    Notes: Production, means the output of Single Nucleotide Polymorphism (SNP) Genotyping Revenue, means the sales value of Single Nucleotide Polymorphism (SNP) Genotyping This report studies Single Nucleotide Polymorphism (SNP) Genotyping in Global market, especially in EU Total, USA Total, Japan Total, China Total, Global Other and , focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, coverin......
  • Global DNA Forensic Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 27-Dec-2016        Price: US 3480 Onwards        Pages: 118
    DNA forensics is a branch of forensic science that focuses on the use of genetic material in criminal investigation to answer questions pertaining to legal situations, including criminal and civil cases.Scope of the Report:This report focuses on the DNA Forensic in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.Mar......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs